Cidara Therapeutics to Present Ongoing Development of
SAN DIEGO, June 20, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics...
Stay updated with breaking news from Preclinical Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN DIEGO, June 20, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics...
SAN DIEGO, June 20, 2023 -- Cidara Therapeutics, Inc. , a biotechnology company developing long-acting therapeutics designed to help improve the standard of care for patients facing serious... | June 20, 2023
Toronto, ON (PRWEB) June 02, 2023 -- Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical
Toronto, ON (PRWEB) May 25, 2023 -- Protein kinases act as master regulators of multiple key processes within the cell cycle, and aberrant regulation of their
BOSTON & SEATTLE--(BUSINESS WIRE)--May 25, 2023--